Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network
Abstract To develop an artificial intelligence (AI) model that predicts anti-vascular endothelial growth factor (VEGF) agent-specific anatomical treatment outcomes in neovascular age-related macular degeneration (AMD), thereby assisting clinicians in selecting the most suitable anti-VEGF agent for e...
Main Authors: | Sehwan Moon, Youngsuk Lee, Jeongyoung Hwang, Chul Gu Kim, Jong Woo Kim, Won Tae Yoon, Jae Hui Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-32398-7 |
Similar Items
-
Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Jae-Hui Kim, et al.
Published: (2021-08-01) -
Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
by: Bo-Hyun Moon, et al.
Published: (2023-08-01) -
Impact of Delayed Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Due to the Coronavirus Disease Pandemic on the Prognosis of Patients with Neovascular Age-Related Macular Degeneration
by: Jae-Gon Kim, et al.
Published: (2022-04-01) -
Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
by: Seungheon Lee, et al.
Published: (2023-03-01) -
Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
by: Han Joo Cho, et al.
Published: (2022-09-01)